ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,537Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 96

$983K Total Retail Price of All Prescriptions

Rank: 9 out of 96

616 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 616 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

7% of this provider’s 616 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 14,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 537 529 1 3
FUROSEMIDE 529 498 2 4
DONEPEZIL HCL 470 470 3 8
FAMOTIDINE 432 423 4 21
ESCITALOPRAM OXALATE 422 397 5 24
SIMVASTATIN 422 407 5 1
WARFARIN SODIUM 403 399 7 6
AMLODIPINE BESYLATE 367 367 8 2
NAMENDA 313 301 9 11
METOPROLOL TARTRATE 312 310 10 7
OMEPRAZOLE 311 301 11 5
MIRTAZAPINE 264 264 12 14
POTASSIUM CHLORIDE 224 198 13 19
METOPROLOL SUCCINATE 219 209 14 9
SERTRALINE HCL 204 204 15 15
RISPERIDONE 195 195 16 31
DIOVAN 182 168 17 17
LISINOPRIL 182 182 17 10
GABAPENTIN 179 172 19 20
TRAZODONE HCL 177 177 20 38
MELOXICAM 158 145 21 65
CLOPIDOGREL 156 148 22 27
OLANZAPINE 156 155 22 76
QUETIAPINE FUMARATE 153 133 24 32
ENALAPRIL MALEATE 151 128 25 28
TAMSULOSIN HCL 146 141 26 29
METFORMIN HCL 146 134 26 13
CYMBALTA 140 127 28 51
HYDROCHLOROTHIAZIDE 139 135 29 16
LIDODERM 128 128 30 45
LEXAPRO 121 110 31 92
GLIPIZIDE 118 118 32 62
CARVEDILOL 115 115 33 22
EXELON 114 102 34 47
TORSEMIDE 114 114 34 109
LEVETIRACETAM 103 91 36 61
HYDROCODONE-ACETAMINOPHEN 103 95 S3 36 52
PANTOPRAZOLE SODIUM 101 95 38 44
ATORVASTATIN CALCIUM 100 99 39 12
ZOLPIDEM TARTRATE 99 97 40 18
FENTANYL 90 90 S2 41 50
SEROQUEL 88 79 42 106
ALLOPURINOL 86 80 43 82
DIGOXIN 83 82 44 34
ALENDRONATE SODIUM 83 83 44 36
SINGULAIR 81 81 46 78
SUCRALFATE 81 76 46 176
ADVAIR DISKUS 79 69 48 46
LATANOPROST 79 79 48 77
ATENOLOL 78 78 50 30
DIVALPROEX SODIUM 75 70 51 41
RAMIPRIL 74 74 52 69
CARBIDOPA-LEVODOPA 72 72 53 48
PLAVIX 72 72 53 42
TRICOR 70 62 55 111
METOLAZONE 69 69 56 179
JANUVIA 67 54 57 49
BYSTOLIC 64 60 58 56
CIPROFLOXACIN HCL 64 63 58 97
PREDNISONE 63 61 60 58
DILTIAZEM 24HR CD 62 62 61 83
LYRICA 62 56 61 73
IPRATROPIUM-ALBUTEROL 61 59 63 57
NYSTATIN 59 53 64 86
FLUOXETINE HCL 58 45 65 107
CITALOPRAM HBR 56 56 66 25
AZITHROMYCIN 54 48 67 54
ABILIFY 54 46 67 122
NOVOFINE AUTOCOVER 53 43 69 141
CARAFATE 53 52 69 177
NITROGLYCERIN PATCH 51 51 71 89
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 46 71 127
METOCLOPRAMIDE HCL 51 50 71 190
NOVOLOG 51 51 71 142
OXYCODONE-ACETAMINOPHEN 50 43 S2 75 26
AMIODARONE HCL 50 50 75 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.